TRAVERE THERAPEUTICS INC's ticker is and the CUSIP is 89422GAA5. A total of 27 filers reported holding TRAVERE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,217,315 | +202.0% | 26,500,000 | +278.6% | 0.72% | +184.9% |
| Q2 2023 | $5,700,520 | +27064.7% | 7,000,000 | -67.3% | 0.25% | -67.5% |
| Q1 2023 | $20,985 | +128.6% | 21,382,000 | +112.1% | 0.77% | +205.1% |
| Q4 2022 | $9,181 | -99.9% | 10,082,000 | -32.8% | 0.25% | +17.7% |
| Q3 2022 | $15,310,000 | -19.5% | 15,000,000 | -21.1% | 0.22% | -50.3% |
| Q2 2022 | $19,009,000 | -4.8% | 19,000,000 | 0.0% | 0.43% | -6.9% |
| Q1 2022 | $19,967,000 | – | 19,000,000 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 18,167 | $17,858 | 1.50% |
| BRAIDWELL LP | 28,350,000 | $27,868,050 | 0.92% |
| READYSTATE ASSET MANAGEMENT LP | 9,000,000 | $8,847,000 | 0.82% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 21,382,000 | $20,985 | 0.77% |
| UBS OCONNOR LLC | 20,000,000 | $19,700,500 | 0.60% |
| CSS LLC/IL | 8,178,000 | $8,038,680 | 0.53% |
| WOLVERINE ASSET MANAGEMENT LLC | 37,900,000 | $37,317,810 | 0.44% |
| Segantii Capital Management Ltd | 10,000,000 | $9,827,050 | 0.34% |
| LINDEN ADVISORS LP | 28,993,000 | $28,511,354 | 0.30% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 30,893,000 | $30,367,819 | 0.15% |